Type 1 Diabetes Mellitus (T1DM) self management in hospital; Is it possible? A literature review

School of Nursing and Midwifery, Flinders University, Adelaide, SA, Australia.
Contemporary nurse: a journal for the Australian nursing profession (Impact Factor: 0.65). 02/2012; 40(2):179-93. DOI: 10.5172/conu.2012.40.2.179
Source: PubMed


To review research evidence on the adults with type 1 diabetes mellitus (T1DM)'s ability to continue self management in the hospital setting.
A person with T1DM requires a daily management routine to control glycaemia levels known as self management. On admission to hospital anecdotal evidence suggests people with T1DM are managed by health professionals and self management is difficult. A review of the literature is required to explore the anecdotal evidence.
A literature review of available primary peer-reviewed research on self management of T1DM in hospital.
A systematic search of the literature published between 1998 and 2008 was undertaken to identify research available on self management of T1DM in hospital. The mixed methods review was conducted using critique tools for randomised control trials, qualitative and quantitative studies. Four main themes were identified; Glycaemic control, development of self management, the expert patient and T1DM management in hospital.
Sixteen related publications were identified. In the context of their daily life adults with T1DM perceive their ability to self manage as important and view themselves as 'experts' in their self management. However, there is a recognised conflict about T1DM management between the 'expert' and health professional. Furthermore, management of T1DM by health professionals in the hospital setting has been identified as having a biomedical focus and being poorly managed.
People with T1DM have knowledge and skills to self manage. Whilst there is support for adults to actively self manage their illness to maintain glycaemic control, there is no support in the literature regarding a continuation of self management in the hospital setting.

Download full-text


Available from: Alison Hutton, Oct 05, 2015
1 Follower
49 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients with type 1 diabetes mellitus (T1DM) have minimal to absent pancreatic β-cell function and rely on the exogenous delivery of insulin to obtain adequate and life-sustaining glucose homeostasis. Maintaining glycemic control is challenging in hospitalized patients with T1DM, as insulin requirements are influenced by the presence of acute medical or surgical conditions, as well as altered nutritional intake. The risks of hyperglycemia, ketoacidosis, hypoglycemia, and glycemic variability are increased in hospitalized patients with T1DM. Diabetic ketoacidosis and severe hypoglycemia are the 2 most common emergency conditions that account for the majority of hospital admissions in patients with T1DM. The association between hyperglycemia and increased risk of complications and mortality in patients with type 2 diabetes (T2DM) is well established; however, the impact of glycemic control on clinical outcomes has not been determined in patients with T1DM who present without ketoacidosis. To decrease complications associated with insulin therapy, health care professionals must be well versed in the use of insulin because it is a common source of medication error. For non-critically ill, hospitalized patients, subcutaneous insulin given to cover basal and prandial needs instead of sliding scale is the preferred method of insulin dosing. Protocols are available for initiating and titrating insulin doses, as well as for transitioning from an insulin infusion to a subcutaneous regimen. In our review, we identify and discuss special considerations related to inpatient glycemic control of non-ketotic patients with T1DM. Additionally, point differences and similarities associated with the management of patients with T2DM are discussed.
    Hospital practice (1995) 08/2013; 41(3):89-100. DOI:10.3810/hp.2013.08.1072
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The metabolic syndrome creates risk factors for coronary heart disease, diabetes, fatty liver, obesity and several cancers. Our group has already reported that the essential oil from leaves of Pinus koraiensis SIEB (EOPK) exerted antihyperlipidemic effects by upregulating the low-density lipoprotein receptor and inhibiting acyl-coenzyme A, cholesterol acyltransferases. We evaluated in the current study the anti-diabetic effects of EOPK on mice with streptozotocin (STZ)-induced type I diabetes and on HIT-T15 pancreatic β cells. EOPK significantly protected HIT-T15 cells from STZ-induced cytotoxicity and reduced the blood glucose level in STZ-induced diabetic mice when compared with the untreated control. EOPK consistently and significantly suppressed the α-amylase activity in a dose-dependent manner and enhanced the expression of insulin at the mRNA level in STZ-treated HIT-T15 cells, while the expression of insulin was attenuated. EOPK also significantly abrogated the population of reactive oxygen species when compared to the untreated control in STZ-treated HIT-T15 cells. Furthermore, EOPK significantly reduce nitric oxide production, suppressed the phosphorylation of endothelial nitric oxide (NO) synthase and suppressed the production of vascular endothelial growth factor (VEGF) in STZ-treated HIT-T15 cells, implying its potential application to diabetic retinopathy. Overall, our findings suggest that EOPK had hypoglycemic potential by inhibiting reactive oxygene species (ROS), endothelial NO synthase (eNOS) and VEGF in STZ-treated mice and HIT-T15 pancreatic β cells as a potent anti-diabetic agent.
    Bioscience Biotechnology and Biochemistry 10/2013; 77(10). DOI:10.1271/bbb.130254 · 1.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ensuring safe and appropriate use of antihyperglycemic agents in hospital is a challenge. It requires that the contraindications and precautions to the use of non-insulin agents be observed, the incidence of hypoglycemia and severe hyperglycemia be minimized, and the risk of medication errors (including inappropriate prescribing) be reduced. Insulin is a high-alert medication with an increased risk for causing patient harm when prescribed inappropriately or administered in error. Reduction in the risk for medication error requires close attention to the many detailed steps in the various phases of the medication-use process. Hypoglycemia is often caused by failure to adjust antihyperglycemic therapy in response to a reduction in nutritional intake. Treatment needs to be more closely linked to patients' nutritional status, and nursing staff should be empowered to initiate prompt reversal of hypoglycemia. Hyperglycemia commonly results from reliance on sliding-scale insulin as the sole method of controlling blood glucose or failure to optimize treatment by increasing the dose of insulin. Suboptimal prescribing of insulin may be due to a lack of knowledge and expertise on the part of the prescriber or fear of causing hypoglycemia. Strategies for improvement of glycemic control include education of care providers on the safe and appropriate use of insulin, establishment of standardized protocols (i.e. order sets) for insulin use and provision of clinical decision aids at the point of care to guide prescribers. Considering the challenges and obstacles faced by hospitals, establishment of a multidisciplinary committee is recommended for the purpose of directing efforts at quality improvement of diabetes care within the hospital.
    Canadian Journal of Diabetes 04/2014; 38(2):94–100. DOI:10.1016/j.jcjd.2014.01.002 · 2.00 Impact Factor
Show more